Third Circuit Defines FCA § 3730(h) “Other Efforts” Protected Activity: Objectively Reasonable Belief of False Claims Required; Rule 9(b) Does Not Apply

1. Introduction

In Paul Lisenby v. Olympus Corporation of the Americas (3d Cir. Aug. 4, 2026), the Third Circuit addressed a recurring problem in False Claims Act (“FCA”) retaliation litigation: when an employee reports regulatory or safety concerns at a federal contractor, when (if ever) does that become protected whistleblowing “to stop” an FCA violation?

Paul Lisenby, a senior product-development executive at Olympus’s U.S. subsidiaries, internally raised concerns that Olympus’s medical-device design controls and testing violated FDA regulations and created patient-safety risks. Soon after, Olympus eliminated his position. Lisenby sued under the FCA’s anti-retaliation provision, 31 U.S.C. § 3730(h)(1), claiming he engaged in protected “other efforts to stop” FCA violations. The District Court dismissed, reasoning his allegations did not connect FDA-regulatory concerns to the submission (or planned submission) of false claims for federal payment. The Third Circuit affirmed, but in doing so announced two important precedential rules governing FCA retaliation pleading and protected activity.

2. Summary of the Opinion

The Third Circuit held:

  • Rule 9(b) does not apply to FCA retaliation claims under 31 U.S.C. § 3730(h); the ordinary Rule 8(a) plausibility standard governs.
  • Under the § 3730(h)(1) “other efforts” prong, a plaintiff engages in protected conduct only when the conduct is motivated by an objectively reasonable belief that the employer has submitted, is submitting, or will submit a false or fraudulent claim for payment or approval to the federal government.
  • Because Lisenby alleged internal warnings about FDA noncompliance and patient safety—but did not allege he believed Olympus was committing fraud on the government via false claims—he failed to plead protected conduct, and dismissal was affirmed.

3. Analysis

A. Precedents Cited

1) United States ex rel. Ascolese v. Shoemaker Constr. Co.

Ascolese (55 F.4th 188 (3d Cir. 2022)) supplied the crucial statutory backdrop: Congress’s 2009–2010 amendments expanded § 3730(h) beyond acts “in furtherance of” an FCA action to include “other efforts to stop” violations. In Lisenby, the court built on Ascolese by supplying the missing doctrinal test—what “other efforts” must look like to qualify as protected conduct.

2) DiFiore v. CSL Behring, LLC; Hutchins v. Wilentz, Goldman & Spitzer

The court relied on DiFiore v. CSL Behring, LLC, 879 F.3d 71 (3d Cir. 2018) and Hutchins v. Wilentz, Goldman & Spitzer, 253 F.3d 176 (3d Cir. 2001) for the basic elements of an FCA retaliation claim and related requirements:

  • protected conduct;
  • discrimination because of protected conduct;
  • employer notice of protected conduct (Ascolese); and
  • “but-for” causation (DiFiore).

Those cases framed the analysis, but the new contribution in Lisenby is defining protected conduct under the “other efforts” prong.

3) Foglia v. Renal Ventures Mgmt., LLC (and the Rule 9(b) question)

Foglia v. Renal Ventures Mgmt., LLC, 754 F.3d 153 (3d Cir. 2014) was cited to confirm that substantive FCA fraud claims must satisfy Rule 9(b). Lisenby contrasts that principle with retaliation: § 3730(h) does not itself allege fraud; it alleges discriminatory retaliation. Accordingly, the court aligned with every circuit to address the issue and held Rule 8(a)—not Rule 9(b)—governs FCA retaliation pleadings.

4) Universal Health Servs., Inc. v. United States ex rel. Escobar (implied false certification)

Lisenby attempted to convert FDA noncompliance into a “reasonable belief” of FCA fraud by invoking implied false certification under Universal Health Servs., Inc. v. United States ex rel. Escobar, 579 U.S. 176 (2016). The Third Circuit treated Escobar as important but not dispositive for retaliation: a plausible theory of FCA liability in the abstract does not substitute for allegations that this employee believed Olympus was defrauding the government by submitting (or preparing to submit) false payment claims.

5) Singletary v. Howard Univ. and other “other efforts” circuit cases

The court drew heavily from sister-circuit interpretations requiring a connection to fraud in claims for government funds, including:

  • Singletary v. Howard Univ., 939 F.3d 287 (D.C. Cir. 2019)
  • Hickman v. Spirit of Athens, Ala., Inc., 985 F.3d 1284 (11th Cir. 2021)
  • United States ex rel. Reed v. KeyPoint Gov't Sols., 923 F.3d 729 (10th Cir. 2019)
  • United States ex rel. Grant v. United Airlines, Inc., 912 F.3d 190 (4th Cir. 2018)

The court distinguished Singletary factually: there, the complaint alleged the employee connected regulatory noncompliance to the university’s certifications required to obtain and retain NIH funding—i.e., a pleaded link between compliance statements and federal money. In Lisenby, the pleaded narrative stopped at FDA noncompliance and patient harm, without allegations of a belief about false payment claims.

6) Anti-retaliation analogies (Title VII, ADA, ADEA, EMTALA)

To justify adopting the “objectively reasonable belief” standard, the court analogized to Third Circuit retaliation doctrine under other statutes, including:

  • Moore v. City of Philadelphia, 461 F.3d 331 (3d Cir. 2006) (Title VII)
  • Williams v. Phila. Hous. Auth. Police Dep't, 380 F.3d 751 (3d Cir. 2004) (ADA retaliation)
  • Daniels v. Sch. Dist. of Phila., 776 F.3d 181 (3d Cir. 2015) (ADEA)
  • Gillispie v. RegionalCare Hosp. Partners, Inc., 892 F.3d 585 (3d Cir. 2018) (EMTALA)

This cross-statute approach underscores that the court viewed “other efforts” as a preventative anti-retaliation regime, not an invitation to litigate generalized compliance concerns untethered to the FCA’s core: false claims for federal money.

B. Legal Reasoning

1) Rule 9(b) vs. Rule 8(a)

The court reasoned that while FCA liability under § 3729 is fraud-based (and thus pleaded with particularity under Rule 9(b)), retaliation under § 3730(h) is employment discrimination “because of” protected whistleblowing. Since retaliation does not itself allege the defendant submitted fraudulent claims, Rule 8(a) applies.

2) The “other efforts” nexus to an FCA violation

The opinion’s core interpretive move is textual: § 3730(h)(1) protects “other efforts to stop 1 or more violations of this subchapter.” Because the “subchapter” is about false or fraudulent claims for federal payment or approval, protected “other efforts” must relate to stopping that kind of fraud—not merely stopping regulatory violations in the abstract.

3) The “objectively reasonable belief” standard (subjective + objective)

The Third Circuit adopted a two-part standard:

  • Subjective: the employee believed in good faith the employer was violating (or about to violate) the FCA.
  • Objective: a reasonable employee in similar circumstances would believe the employer was submitting (or would submit) false claims for payment.

The court described this as a “relatively low bar,” consistent with the “preventative” purpose of “other efforts,” while also preserving the FCA’s goal of limiting opportunistic suits.

4) Application to Lisenby’s allegations

Even accepting that Olympus was a major federal contractor and that FDA noncompliance could theoretically lead to FCA liability, the complaint did not plead facts supporting an inference that Lisenby’s internal advocacy was motivated by a belief about false claims for payment. The pleaded communications repeatedly referenced FDA compliance, design controls, and patient safety—not fraud on federal payors. That gap was fatal to protected-conduct pleading under the newly announced standard.

C. Impact

1) A clearer Third Circuit test for “other efforts” protected activity

The case creates a controlling Third Circuit standard: “other efforts” are protected only when tied to an objectively reasonable belief about false claims for federal payment/approval. This will likely narrow retaliation claims that rest solely on regulatory, quality, or safety reporting unless plaintiffs plausibly connect those concerns to claim submission, certifications tied to payment, or reimbursement conditions.

2) Pleading strategy: easier on detail, stricter on theory

By rejecting Rule 9(b), the court reduces the level of granular billing detail required in retaliation pleadings. But it simultaneously demands conceptual clarity: the complaint must plausibly allege the employee’s belief (and the reasonableness of that belief) that the employer’s conduct implicated false claims to the federal government.

3) Compliance vs. FCA risk

The decision draws a line between “compliance whistleblowing” and “FCA whistleblowing.” In regulated industries (medical devices, healthcare, government contracting), internal reports should be framed—if accurate and in good faith—in terms of how noncompliance could translate into false certifications, false statements material to payment, or improper reimbursement claims, if an employee intends FCA retaliation protection to apply.

4. Complex Concepts Simplified

  • False Claims Act (FCA): a federal law imposing liability for knowingly submitting false claims for money to the U.S. government.
  • Qui tam: a private whistleblower suit brought on the government’s behalf, potentially yielding a reward if money is recovered.
  • § 3730(h) retaliation: a separate claim allowing an employee to sue an employer who retaliates because the employee tried to stop FCA violations.
  • “Other efforts” prong: protected actions that try to prevent FCA violations (not necessarily by filing a lawsuit), but they must still concern stopping false-claims fraud.
  • Implied false certification (Escobar): FCA liability may exist when someone seeks payment while concealing noncompliance that makes what they said about the goods/services misleading, and the noncompliance is material to payment.
  • Rule 9(b) vs. Rule 8(a): Rule 9(b) requires fraud details (who/what/when/where/how); Rule 8(a) requires only a plausible, notice-giving claim. Lisenby holds FCA retaliation uses Rule 8(a).
  • Objectively reasonable belief: the employee actually believed (good faith) and a reasonable person in similar circumstances would also believe the employer was engaged in (or about to engage in) false-claims fraud.

5. Conclusion

Lisenby is a precedential Third Circuit decision that both (1) confirms FCA retaliation claims are governed by Rule 8(a), not Rule 9(b), and (2) establishes a definitive standard for protected conduct under the FCA’s “other efforts” prong: the employee must act from an objectively reasonable belief that the employer has submitted, is submitting, or will submit false or fraudulent claims for federal payment or approval. The ruling strengthens doctrinal clarity in FCA retaliation litigation by distinguishing regulatory- or safety-focused reporting from FCA-protected activity unless the complaint plausibly links those concerns to fraud on the federal fisc.